Johnson & Johnson (JNJ)
NYSE · Healthcare
Johnson & Johnson Shareholder Equity 2017–2025
Johnson & Johnson annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Johnson & Johnson shareholder equity as of December 28, 2025: 81.54B, a 14.06% increase year-over-year.
- Johnson & Johnson shareholder equity for 2025 were 81.54B, a 14.06% increase from 2024.
- Johnson & Johnson shareholder equity for 2024 were 71.49B, a 3.95% increase from 2023.
- Johnson & Johnson shareholder equity for 2023 were 68.77B, a 7.09% decrease from 2022.
- Johnson & Johnson shareholder equity for 2022 were 74.02B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Johnson & Johnson Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $81,544 |
| 2024 | $71,490 |
| 2023 | $68,774 |
| 2022 | $74,023 |
| 2021 | $63,278 |
| 2019 | $59,471 |
| 2018 | $59,752 |
| 2017 | $60,160 |
Johnson & Johnson Shareholder Equity — FAQ
Johnson & Johnson (JNJ) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see JNJ's shareholder equity history?
The chart and table above show Johnson & Johnson's shareholder equity by year and by quarter, including the growth rate.